Literature DB >> 32285168

The Causes of Hypo- and Hyperphosphatemia in Humans.

Eugénie Koumakis1, Catherine Cormier2, Christian Roux2, Karine Briot2.   

Abstract

Phosphate homeostasis involves several major organs that are the skeleton, the intestine, the kidney, and parathyroid glands. Major regulators of phosphate homeostasis are parathormone, fibroblast growth factor 23, 1,25-dihydroxyvitamin D, which respond to variations of serum phosphate levels and act to increase or decrease intestinal absorption and renal tubular reabsorption, through the modulation of expression of transcellular transporters at the intestinal and/or renal tubular level. Any acquired or genetic dysfunction in these major organs or regulators may induce hypo- or hyperphosphatemia. The causes of hypo- and hyperphosphatemia are numerous. This review develops the main causes of acquired and genetic hypo- and hyperphosphatemia.

Entities:  

Keywords:  Hyperphosphatemia; Hypophosphatemia; Parathyroid hormone; Phosphate depletion; Phosphate regulation; Phosphates; Phosphatonins; Vitamin D

Year:  2020        PMID: 32285168     DOI: 10.1007/s00223-020-00664-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  184 in total

1.  Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression.

Authors:  H M Hoag; J Martel; C Gauthier; H S Tenenhouse
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  Genetic disorders of renal phosphate transport.

Authors:  Dominique Prié; Gérard Friedlander
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

3.  Phosphate transport in human jejunal brush-border membrane vesicles.

Authors:  S M Borowitz; F K Ghishan
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

4.  Hypophosphataemia and hyperphosphataemia in a hospital population.

Authors:  M G Betro; R W Pain
Journal:  Br Med J       Date:  1972-01-29

Review 5.  Hypophosphatemia: an update on its etiology and treatment.

Authors:  André Gaasbeek; A Edo Meinders
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

6.  Regulation of the human sodium-phosphate cotransporter NaP(i)-IIb gene promoter by epidermal growth factor.

Authors:  H Xu; J F Collins; L Bai; P R Kiela; F K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2001-03       Impact factor: 4.249

7.  Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake.

Authors:  O Hattenhauer; M Traebert; H Murer; J Biber
Journal:  Am J Physiol       Date:  1999-10

8.  Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting.

Authors:  S Shenolikar; J W Voltz; C M Minkoff; J B Wade; E J Weinman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

9.  Regulation of intestinal NaPi-IIb cotransporter gene expression by estrogen.

Authors:  Hua Xu; Jennifer K Uno; Michael Inouye; Liping Xu; Jason B Drees; James F Collins; Fayez K Ghishan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-07-31       Impact factor: 4.052

Review 10.  Phosphate and FGF-23 homeostasis after kidney transplantation.

Authors:  Leandro C Baia; Ita Pfeferman Heilberg; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2015-09-29       Impact factor: 28.314

View more
  8 in total

1.  Phosphate Metabolism.

Authors:  Salvatore Minisola; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2020-08-09       Impact factor: 4.333

Review 2.  Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.

Authors:  Richard M Shore
Journal:  Pediatr Radiol       Date:  2022-05-10

Review 3.  Phosphate Is a Cardiovascular Toxin.

Authors:  Maren Leifheit-Nestler; Isabel Vogt; Dieter Haffner; Beatrice Richter
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Vitamin D and Phosphate Interactions in Health and Disease.

Authors:  Nuraly S Akimbekov; Ilya Digel; Dinara K Sherelkhan; Mohammed S Razzaque
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis.

Authors:  Wen-He Zheng; Yan Yao; Hua Zhou; Yuan Xu; Hui-Bin Huang
Journal:  Front Med (Lausanne)       Date:  2022-05-17

Review 6.  Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review.

Authors:  S Giannini; M L Bianchi; D Rendina; P Massoletti; D Lazzerini; M L Brandi
Journal:  Osteoporos Int       Date:  2021-05-19       Impact factor: 4.507

Review 7.  Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications.

Authors:  Francesco Vieceli Dalla Sega; Francesca Fortini; Paolo Severi; Paola Rizzo; Iija Gardi; Paolo Cimaglia; Claudio Rapezzi; Luigi Tavazzi; Roberto Ferrari
Journal:  Biology (Basel)       Date:  2022-03-09

8.  An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia.

Authors:  Fahad Aljuraibah; Justine Bacchetta; Maria Luisa Brandi; Pablo Florenzano; Muhammad K Javaid; Outimaija Mäkitie; Adalbert Raimann; Mariano Rodriguez; Heide Siggelkow; Dov Tiosano; Marc Vervloet; Carsten A Wagner
Journal:  J Bone Miner Res       Date:  2021-12-23       Impact factor: 6.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.